Booster dose
Showing 1 - 25 of >10,000
SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)
Not yet recruiting
- SARS-CoV-2
- CV0701 Bivalent High dose
- +4 more
- (no location specified)
Jul 24, 2023
Booster Dose of Comirnaty in Children Ages 6 Months Though 4
Not yet recruiting
- SARS-CoV-2
- COVID-19
- COMIRNATY intramuscular injection
-
Tokyo, JapanPfizer Local Country
Nov 8, 2023
Healthy Trial in Basel (MDMA 120 mg + MDMA 60 mg, MDMA 120 mg + , Placebo)
Not yet recruiting
- Healthy
- MDMA 120 mg + MDMA 60 mg
- +2 more
-
Basel, SwitzerlandUniversity Hospital
Mar 28, 2023
COVID-19 Trial (Invitation to get a 2nd booster dose of COVID-19 vaccine)
Not yet recruiting
- COVID-19
- Invitation to get a 2nd booster dose of COVID-19 vaccine
- (no location specified)
Sep 14, 2022
COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Subunit Recombinant Protein Vaccine
- (no location specified)
Jul 5, 2023
COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)
Active, not recruiting
- COVID-19
- LYB002V14
- +2 more
-
Chengdu, Sichuan, ChinaAffiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023
Ebola Vaccine Trial (ERVEBO® (rVSV?G-ZEBOV-GP))
Not yet recruiting
- Ebola Vaccine
- ERVEBO® (rVSV∆G-ZEBOV-GP)
- (no location specified)
Jul 17, 2023
COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)
Active, not recruiting
- COVID-19
- SCB-2019/Clover
- +2 more
-
Natal, Rio Grande Do Norte, Brazil
- +1 more
Apr 10, 2023
COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)
Active, not recruiting
- COVID-19
- Vaccine Reaction
- LYB001
- CoronaVac
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- COVAC-1
- Saline Placebo
- (no location specified)
Jan 23, 2023
COVID-19, SARS-CoV-2 Trial in London (COVI-VAC)
Completed
- COVID-19
- SARS-CoV-2
- COVI-VAC
-
London, United KingdomHMR
Jan 11, 2023
Inactivated COVID-19 Vaccine of the First Booster Dose
Active, not recruiting
- COVID-19
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Manguinhos, BrazilInstituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ)
Jan 11, 2023
COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)
Recruiting
- COVID-19
- RQ3013
- +2 more
-
Kunming, Yunnan, ChinaThe Affiliated Hospital of Yunnan University
Jun 22, 2023
Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by
Enrolling by invitation
- Humoral Immunity
- Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
-
Gomel, BelarusGomel State Medical University
Jan 30, 2023
Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,
Active, not recruiting
- Immunogenicity
- +2 more
- SW-BIC-213;SARS-Cov-2.
- +2 more
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Jan 8, 2023
COVID-19, SARS CoV 2 Infection Trial in Australia (ChulaCov19 BNA159 vaccine (50 mcg), Pfizer/BNT vaccine (30 mcg))
Not yet recruiting
- COVID-19, SARS CoV 2 Infection
- ChulaCov19 BNA159 vaccine (50 mcg)
- Pfizer/BNT vaccine (30 mcg)
-
Bruce, Australian Capital Territory, Australia
- +4 more
Nov 15, 2022
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Moderna COVID-19 Bivalent Booster for Omicron BA.4/5
Recruiting
- COVID-19
- Moderna COVID-19 Vaccine
- +3 more
-
Culver City, CaliforniaScience37
Mar 9, 2023
COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)
Not yet recruiting
- COVID-19 Respiratory Infection
- COVID-19 Vaccine Adverse Reaction
- DNA vaccine OC-007
- Placebo
-
Stockholm, Region Stockholm, SwedenPhase I Study Unit, Karolinska University Hospital
Jan 13, 2023
COVID-19 Vaccines Trial in Paris (2nd booster with Comirnaty® (Pfizer-BioNTech), CoV2 preS dTM adjuvanted vaccine (B.1.351),
Active, not recruiting
- COVID-19 Vaccines
- 2nd booster with Comirnaty® (Pfizer-BioNTech)
- CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
COVID-19 Trial in Bandung (SARS-CoV-2 subunit protein recombinant vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 subunit protein recombinant vaccine
-
Bandung, Jawa Barat, IndonesiaFaculty of Medicine Universitas Padjadjaran
Feb 13, 2023
Coadministration of Influenza Vaccination With Booster Dose of
Completed
- Co-administration of COVID-19 and Influenza Vaccines
- COMIRNATY
-
Roma, RM, ItalyFondazione Policlinico Gemelli
Mar 10, 2023
Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,
Recruiting
- COVID-19
- ChAdOx1 nCOV-19 vaccine (Vaxzeria)
- +3 more
-
São Paulo, BrazilTechtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023
First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney
Active, not recruiting
- Kidney Diseases
- +5 more
- Booster dose of mRNA vaccine
-
Praha, CzechiaInstitute for Clinical and Experimental Medicine
Aug 2, 2022